A number of doctor-prescribed drugs, including copyright and Semaglutide, fall under the incretin mimetic category . Primarily , these therapies work by mimicking endogenous substances that regulate glucose levels and promote slimming. Though copyright is a specific formulation for diabetes type

Individuals struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Wegovy, is rapidly changing the landscape of weight loss. Approved by regulatory bodies for chronic weight management, Semaglutide acts as a glu